190 related articles for article (PubMed ID: 8400267)
1. Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells.
Delva L; Cornic M; Balitrand N; Guidez F; Micléa JM; Delmer A; Teillet F; Fenaux P; Castaigne S; Degos L
Blood; 1993 Oct; 82(7):2175-81. PubMed ID: 8400267
[TBL] [Abstract][Full Text] [Related]
2. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
Leukemia; 1994; 8 Suppl 2():S16-9. PubMed ID: 7815831
[TBL] [Abstract][Full Text] [Related]
3. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
Leukemia; 1994 Jun; 8(6):914-7. PubMed ID: 8207983
[TBL] [Abstract][Full Text] [Related]
4. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE
Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735
[TBL] [Abstract][Full Text] [Related]
5. Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid.
Tobita T; Takeshita A; Kitamura K; Ohnishi K; Yanagi M; Hiraoka A; Karasuno T; Takeuchi M; Miyawaki S; Ueda R; Naoe T; Ohno R
Blood; 1997 Aug; 90(3):967-73. PubMed ID: 9242525
[TBL] [Abstract][Full Text] [Related]
6. [Biological parameters of the efficiency of retinoic acid in acute leukemia].
Chomienne C; Cornic M; Castaigne S; Lefebvre P; de Thé H; Dejean A; Degos L
C R Seances Soc Biol Fil; 1991; 185(6):456-63. PubMed ID: 1822394
[TBL] [Abstract][Full Text] [Related]
7. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia.
Muindi J; Frankel SR; Miller WH; Jakubowski A; Scheinberg DA; Young CW; Dmitrovsky E; Warrell RP
Blood; 1992 Jan; 79(2):299-303. PubMed ID: 1309668
[TBL] [Abstract][Full Text] [Related]
8. Relapsed acute promyelocytic leukemia previously treated with all-trans retinoic acid: clinical experience with a new synthetic retinoid, Am-80.
Takeuchi M; Yano T; Omoto E; Takahashi K; Kibata M; Shudo K; Harada M; Ueda R; Ohno R
Leuk Lymphoma; 1998 Nov; 31(5-6):441-51. PubMed ID: 9922035
[TBL] [Abstract][Full Text] [Related]
9. Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient.
Guidez F; Huang W; Tong JH; Dubois C; Balitrand N; Waxman S; Michaux JL; Martiat P; Degos L; Chen Z
Leukemia; 1994 Feb; 8(2):312-7. PubMed ID: 8309256
[TBL] [Abstract][Full Text] [Related]
10. All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells.
Chomienne C; Balitrand N; Ballerini P; Castaigne S; de Thé H; Degos L
J Clin Invest; 1991 Dec; 88(6):2150-4. PubMed ID: 1661301
[TBL] [Abstract][Full Text] [Related]
11. Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series.
Tsimberidou AM; Tirado-Gomez M; Andreeff M; O'Brien S; Kantarjian H; Keating M; Lopez-Berestein G; Estey E
Leuk Lymphoma; 2006 Jun; 47(6):1062-8. PubMed ID: 16840198
[TBL] [Abstract][Full Text] [Related]
12. [Differentiation therapy of acute promyelocytic leukemia with all-trans retinoic acid].
Ohno R; Naoe T; Fukutani H
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1016-21. PubMed ID: 8390226
[TBL] [Abstract][Full Text] [Related]
13. Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy.
Ding W; Li YP; Nobile LM; Grills G; Carrera I; Paietta E; Tallman MS; Wiernik PH; Gallagher RE
Blood; 1998 Aug; 92(4):1172-83. PubMed ID: 9694705
[TBL] [Abstract][Full Text] [Related]
14. Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression.
Xu K; Guidez F; Glasow A; Chung D; Petrie K; Stegmaier K; Wang KK; Zhang J; Jing Y; Zelent A; Waxman S
Cancer Res; 2005 Sep; 65(17):7856-65. PubMed ID: 16140955
[TBL] [Abstract][Full Text] [Related]
15. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
16. Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone.
Ohashi H; Ichikawa A; Takagi N; Hotta T; Naoe T; Ohno R; Saito H
Leukemia; 1992 Aug; 6(8):859-62. PubMed ID: 1353552
[TBL] [Abstract][Full Text] [Related]
17. The role of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.
Fenaux P
Acta Haematol; 1993; 89 Suppl 1():22-7. PubMed ID: 8475669
[TBL] [Abstract][Full Text] [Related]
18. All-trans retinoic acid (ATRA)-induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL).
Orfali N; O'Donovan TR; Cahill MR; Benjamin D; Nanus DM; McKenna SL; Gudas LJ; Mongan NP
Eur J Haematol; 2020 Mar; 104(3):236-250. PubMed ID: 31811682
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of semiquantitative reverse transcriptase-polymerase chain reaction assay of PML/retinoic acid receptor alpha mRNA and in vitro differentiation assay as prognostic prediction in acute promyelocytic leukemia treated with all-trans retinoic acid.
Iwakiri R; Inokuchi K; Dan K; Wakabayashi I
Nihon Ika Daigaku Zasshi; 1996 Aug; 63(4):259-67. PubMed ID: 8810554
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid resistance in acute promyelocytic leukemia.
Gallagher RE
Leukemia; 2002 Oct; 16(10):1940-58. PubMed ID: 12357346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]